GSK Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - GlaxoSmithKline PLC

Watchlist Manager

Watchlist

Price: 50.54 USD -1.37% Market Closed

Market Cap: $103.1B

G	GlaxoSmithKline PLC NYSE:GSK	UK
	Nippon Thompson Co Ltd TSE:6480	JP
	Lagardere SA F:LAG	FR
L	Lagardere SA XBER:LAG	FR
O	OFS Capital Corp F:9UD	US
L	LVMH Moet Hennessy Louis Vuitton SE SWB:MOH	FR
M	MKS Instruments Inc SWB:MKT	US
	Ameresco Inc NYSE:AMRC	US
	SoFi Technologies Inc MIL:1SOFI	US
E	ESCO Technologies Inc SWB:ET7	US
B	BYD Co Ltd DUS:BY6A	CN
	TuSimple Holdings Inc OTC:TSPH	US
T	Teladoc Health Inc SWB:4LL	US
N	Natural Grocers By Vitamin Cottage Inc SWB:N2V	US
B	BCE Inc XBER:BCE1	CA
C	Compagnie de Saint Gobain SA DUS:GOB	FR
O	Oil States International Inc XBER:OI2	US

Profitability Summary

GlaxoSmithKline PLC's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

73%

Strong 3Y Average Gross Margin

72%

Gross Margin is Increasing

70% > 73%

Healthy Operating Margin

27%

Sustainable 3Y Average Operating Margin

26%

Operating Margin is Increasing

26% > 27%

Healthy Net Margin

18%

Sustainable 3Y Average Net Margin

17%

Declining Net Margin

50% > 18%

Exceptional Free Cash Flow Margin

15%

Strong 3Y Average Free Cash Flow Margin

14%

Free Cash Flow Margin is Increasing

9% > 15%

Exceptional ROE

36%

Exceptional 3Y Average ROE

Positive 3Y Average ROIC

18%

ROIC is Increasing

14% > 18%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.